Simple jQuery Dropdowns

Browsing by Author Kaan Kavakli

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 2 of 2
Issue DateTitleAuthor(s)
1-Jan-2012Recombinant factor VIIa analog (vatreptacog alfa [activated]) for treatment of joint bleeds in hemophilia patients with inhibitors: A randomized controlled trialErich V. de Paula; Kaan Kavakli; Johnny Mahlangu; Yasmin Ayob; Steven R. Lentz; Massimo Morfini; László Nemes; Silva Z. Šalek; Midori Shima; Jerzy Windyga; Silke Ehrenforth; Ampaiwan Chuansumrit; Universidade Estadual de Campinas; Ege University Medical School; Academic Hospital; National Blood Center; University of Iowa; Azienda Ospedaliera Careggi; National Hemophilia Center; University of Zagreb School of Medicine; Nara Kenritsu Ika Daigaku Fozuku Byoin; Institute of Haematology and Transfusion Medicine, Warsaw; Novo Nordisk AS; Mahidol University
1-Jan-2019Subcutaneous concizumab prophylaxis in hemophilia A and hemophilia A/B with inhibitors: Phase 2 trial resultsAmy D. Shapiro; Pantep Angchaisuksiri; Jan Astermark; Gary Benson; Giancarlo Castaman; Pratima Chowdary; Hermann Eichler; Victor Jiménez-Yuste; Kaan Kavakli; Tadashi Matsushita; Lone Hvitfeldt Poulsen; Allison P. Wheeler; Guy Young; Silva Zupancic-Salek; Johannes Oldenburg; Vanderbilt University Medical Center; Universitäts-Klinikum Bonn und Medizinische Fakultät; Belfast Health and Social Care Trust; Aarhus Universitet; NHS Foundation Trust; Hospital Universitario La Paz; Nagoya University Hospital; Universitätsklinikum des Saarlandes Medizinische Fakultät der Universität des Saarlandes; Ege Üniversitesi; Azienda Ospedaliera Careggi; Josip Juraj Strossmayer University of Osijek; Faculty of Medicine, Ramathibodi Hospital, Mahidol University; Keck School of Medicine of USC; Skånes universitetssjukhus; University of Zagreb School of Medicine; Indiana Hemophilia and Thrombosis Center